Hao-Jie Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hao-Jie Wang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jian-Shu Lou
School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China
2 shared publications Die Hu
1 shared publicationJun-Hu Hu
1 shared publication- Jun-Ying Zhang
School of Pharmacy, Hangzhou Normal University, Hangzhou 311121, China
1 shared publication - Li-Ping Zhao1 shared publication
- Xiao-Qi Tang
School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China
1 shared publication
Latest Publications
- Open Access
Roles of Fascin in Dendritic Cells
Dendritic cells (DCs) are professional antigen-presenting cells that play a crucial role in activating naive T cells through presenting antigen information, thereby influencing immunity and anti-cancer responses. Fascin, a 55-kDa actin-bundling protein, is highly expressed in mature DCs and serves as a marker protein for their identification. However, the precise role of fascin in intratumoral DCs remains poorly understood. In this review, we aim to summarize the role of fascin in both normal and intratumoral DCs. In normal DCs, fascin promotes immune effects through facilitating DC maturation and migration. Through targeting intratumoral DCs, fascin inhibitors enhance anti-tumor immune activity. These roles of fascin in different DC populations offer valuable insights for future research in immunotherapy and strategies aimed at improving cancer treatments.
Open AccessRoles of Fascin in Dendritic Cells
Dendritic cells (DCs) are professional antigen-presenting cells that play a crucial role in activating naive T cells through presenting antigen information, thereby influencing immunity and anti-cancer responses. Fascin, a 55-kDa actin-bundling protein, is highly expressed in mature DCs and serves as a marker protein for their identification. However, the precise role of fascin in intratumoral DCs remains poorly understood. In this review, we aim to summarize the role of fascin in both normal and intratumoral DCs. In normal DCs, fascin promotes immune effects through facilitating DC maturation and migration. Through targeting intratumoral DCs, fascin inhibitors enhance anti-tumor immune activity. These roles of fascin in different DC populations offer valuable insights for future research in immunotherapy and strategies aimed at improving cancer treatments.
- Open Access
- 2 November 2022
- Published by IntechOpen
Ginkgo biloba: A Potential Anti-Cancer Agent
Ginkgo biloba is generally considered as safe herbal extract in clinical application. Ginkgo Folium is a living fossil plant, which has been used in record by over few thousands of years. The extract of G. biloba, has been used extensively for the treatment of diseases related to the central nervous system and psychiatric disorders. Recently, different lines of evidence indicated that G. biloba exhibited anti-cancer effects. The potential therapeutic effect may due to antioxidant, anti-angiogenic and gene regulatory actions. In addition, Ginkgo Folium was studied in pharmacodynamic interactions induced by herb-drug interactions. These studies indicated that G. biloba usually exhibits synergistic effect. The extracts derived from G. biloba exhibits promising anticancer effect, including flavonoids, ginkgolide, and phenolic acids etc. This chapter will discuss the anticancer effect and mechanism of extracts derived from various parts of G. biloba, the possible usage as an adjuvant therapy in cancer treatment, and the development of G. biloba as potential novel anticancer drugs.
- 2 November 2022
- Published by IntechOpen
Open AccessGinkgo biloba: A Potential Anti-Cancer Agent
Ginkgo biloba is generally considered as safe herbal extract in clinical application. Ginkgo Folium is a living fossil plant, which has been used in record by over few thousands of years. The extract of G. biloba, has been used extensively for the treatment of diseases related to the central nervous system and psychiatric disorders. Recently, different lines of evidence indicated that G. biloba exhibited anti-cancer effects. The potential therapeutic effect may due to antioxidant, anti-angiogenic and gene regulatory actions. In addition, Ginkgo Folium was studied in pharmacodynamic interactions induced by herb-drug interactions. These studies indicated that G. biloba usually exhibits synergistic effect. The extracts derived from G. biloba exhibits promising anticancer effect, including flavonoids, ginkgolide, and phenolic acids etc. This chapter will discuss the anticancer effect and mechanism of extracts derived from various parts of G. biloba, the possible usage as an adjuvant therapy in cancer treatment, and the development of G. biloba as potential novel anticancer drugs.